Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aquaporin announces successful completion of Offering of new shares in connection with private placement, raising gross proceeds of DKK 74 million

Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694 Company announcementNo. 14/2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND DOES NOT CONSTITUTE A PUBLIC OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.  Kongens Lyngby, Denmark,February 21, 2023– The Board of

Bokslutskommuniké 1 JANUARI – 31 DECEMBER 2022 FLOWSCAPE TECHNOLOGY AB (publ), ORG.Nr. 556725-4866

Styrelsen och verkställande direktören för Flowscape Technology AB avger härmed rapport för perioden januari – december 2022. Belopp anges i tusentals kronor. Siffror inom parentes avser motsvarande period föregående år. This information is only available in swedish.Januari – December i korthet, koncern HELÅRET (JANUARI-DECEMBER) · Omsättningen uppgick till 41 067 (32 962) TSEK · Rörelseresultat före avskrivningar uppgick till -2 364 (1 356) TSEK · Resultat efter finansiella poster uppgick till -25 570 (-22 386) TSEK · Inkomna ordrar uppgick till 26 247 (26 727) TSEK, varav

XNK Therapeutics to present at Redeye’s Regenerative Medicine/Cell Therapy event on February 22

XNK Therapeutics AB’s CEO Johan Liwing will present at Redeye’s Regenerative Medicine/Cell Therapy event on February 22 between 09:00-12:00 CET.XNK’s presentation starts at 09:10 and is followed at 09:55 by a panel discussion regarding cell therapy for cancer. The presentation is broadcasted live starting at 09:00 and can be followed at: https://www.redeye.se/events/868745/redeye-theme-regenerative-medicine-cell-therapy-2 For more information, please contact: Johan Liwing, CEO, XNK Therapeutics Tel: +46 706 70 36 75 E-mail: johan.liwing@xnktherapeutics.com About XNK

BPC Instruments reports fourth quarter and full-year results 2022

BPC Instruments (“BPC” or “the Company”) hereby publishes the year-end report for the period January 1 – December 31, 2022. The year-end report is available as an attached file to this release and on the Company’s website (www.bpcinstruments.com ). Below is a summary of the report.CEO Dr. Jing Liu comments: “As we close the books on the financial year of 2022 we recognize that BPC’s strong growth continued with an impressive net sales increase of +27 percent, amounting to over SEK 33.5 million, compared to SEK 26.4 million in 2021. Our EBIT

The new TANGO XP espresso line launched by UNIC

To continue to take advantage of the fast-growing espresso coffee market, UNIC, part of Electrolux Professional Group, is launching a new range of super-automatic, high-performing espresso machines, the TANGO[®] XP line.The range includes single and double output models and is dedicated to coffee professionals who place high expectations on premium coffee extraction. Philippe Zavattiero, President Business Area Beverage & Food Preparation comments: “In 2019, the Group acquired UNIC to enter the fast-growing espresso coffee market, a trend that today is even stronger. With the launch of

Saab Responds to NATO RFI with GlobalEye

Saab has responded to a Request for Information (RFI) from NATO’s Support and Procurement Agency regarding a new generation of surveillance and control capabilities. Saab’s response is based on GlobalEye.NATO will define its new generation capability within the Alliance Future Surveillance and Control (AFSC) project. “Saab is a proven and trusted part of NATO’s defence industrial base and we are present in more than two thirds of the member nations. Our solutions, including GlobalEye, are from the outset developed to be compliant with NATO’s requirements. I am confident that we can

Year-end Report January-December 2022

Corem Kelly AB, renamed from Klövern AB in 2022, is consolidated in Corem from 15 June 2021.  · Income increased to SEK 4,491 million (2,805).  · Net operating income increased to SEK 2,933 million (1,894).  · Net financial items amounted to SEK –1,071 million (–579), of which dividends from shareholdings amounted to SEK 67 million (106).  · Profit from property management increased to SEK 1,675 million (1,178).  · Changes in value of properties amounted to SEK –2,934 million (3,432).  · Changes in value of financial assets at fair value amounted to SEK –1,

Year-end Report January – December 2022

This year-end report 2022 has been prepared for the purpose of complying with the terms of Corem Kelly AB’s (publ) bond and loan agreements.   On 29 March 2021, Corem Property Group AB (publ) announced a public offer to the shareholders of Klövern AB (publ). Klövern's shares were delisted from Nasdaq Stockholm in July 2021, following a declaration that the offer was unconditional. After a resolution at the Annual General Meeting on 27 April 2022 Klövern AB has been renamed Corem Kelly AB.   JANUARY–DECEMBER 2022 · Income amounted to SEK 3,467 million (3,274).  · Profit

MPC Container Ships: Invitation to Q4 2022 Earnings Call

MPC Container Ships ASA will publish its Q4 2022 financial report on Tuesday, February 28, 2023. Constantin Baack, CEO, and Moritz Fuhrman, CFO, will present the results in an earnings call at 15:00 CET / 09:00 ET on February 28, 2023, followed by a  Q&A session. The earnings call can be accessed live via webcast or conference call and questions can be submitted orally or in writing. A recording of the earnings call will be available on demand at the Company's website after the live event has concluded. The live webcast can be accessed via the following link: https://edge.media-

Embellence Group Interim Report Q4 2022

Continued healthy profitability despite headwind in Nordic demandFourth quarter 2022 · Net sales amounted to MSEK 176.9 (174.0), up 1.7%. Acquisition-based growth of 16.1%, exchange rate effects of 2.1% and organic growth of –16.5% · EBITA amounted to MSEK 14.7 (25.8). · Adjusted EBITA* amounted to MSEK 22.0 (30.4) · Net profit for the period amounted to MSEK 9.9 (18.4), and earnings per share for the period before dilution were SEK 0.44 (0.86) · Operating cash flow amounted to MSEK 16.0 (15.3) Significant events during the quarter · Karin Lidén became new CFO of

Year-end report 1 January – 31 December 2022

Net sales increases with 94 percent and EBITA improves with 96 percentFOURTH QUARTER 2022 · Net sales increased by 94 percent to MSEK 401 (206). In unchanged currency levels, net sales increased by 90 percent. · Operating profit before amortization of intangible assets (EBITA) increased by 96 percent to MSEK 31 (16) including MSEK -0.8 (-0.6) attributable to unrealized exchange rate gains and losses together with MSEK 1.6 (0) attributable to previously set aside contingent consideration for Alcadon Belgium (formerly 6X International BV). · Cash flow from operating activities

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseFebruary 21, 2023, at 9.00 am EETRepurchase of Outokumpu’s own shares On February 20, 2023, Outokumpu has completed repurchases its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |40,852 |5.5818

OssDsign AB (publ) publishes Year-end Report 2022

A year of sustained high growth and demonstrated scalabilityThe fourth quarter in figures · Net sales amounted to TSEK 19,929 (9,174) · Loss after taxes amounted to TSEK 31,948 (28,726).  · Earnings per share was SEK -0.5 (-0.5). · Cash flow from current operations was TSEK –25,687 (-20,456).  The full year in figures · Net sales amounted to TSEK 56,985 (31,726). · Loss after taxes amounted to TSEK 99,388 (94,077). · Earnings per share was SEK –1.7 (-1.9). · Cash flow from current operations was TSEK –88,975 (-89,629).  Important events during the

Year-end report, January–December 2022

Record quarter and eventful start to 2023January–December 2022 · Revenue increased to TSEK 356,993 (191,378) · Operating profit/loss amounted to TSEK -46,958 (-113,383) · Profit/loss after tax amounted to TSEK -2,079 (-83,854) · Earnings per share amounted to SEK -0.04 (-1.78) · Cash flow for the period amounted to TSEK -161,291 (208,880) · The Board of Directors proposes that no dividend be paid for the financial year 2022 October–December 2022 · Revenue increased to TSEK 101,109 (73,209) · Operating profit/loss amounted to TSEK -8,685 (-29,030) · Profit/

DSV partners with SAS

DSV is the first company in Denmark to sign an agreement within the SAS Corporate Sustainability Program. This partnership means DSV will buy sustainable aviation fuel for all its corporate travel with SAS for 2023.The main lever for decarbonizing the aviation sector is to replace fossil fuels (kerosene) with sustainable aviation fuels (SAF). SAS now accelerates partnerships with corporate customers to expand the use of SAF. The signing marks the start of SAS Corporate Sustainability Program, an initiative designed to meet the demand to easily buy sustainable aviation fuel and thereby

Stayble Therapeutics publishes year-end report for 2022

Stayble Therapeutics AB ("Stayble" or the "Company") hereby publishes its year-end report for 2022. The report is available as an attached document and on the Company's website, https://staybletherapeutics.com/investor-relations/financial-reports/. Below is a summary of the report.Financial information and commentary Stayble Therapeutics AB reported operating expenses of KSEK 4,642 (4,594) for the period October-December 2022. The company had increased costs in the period 1 January to 31 December compared to the previous year. This is directly linked to the positive increase in

Ponsse's Financial Statements for 1 January - 31 December 2022

PONSSE PLC, STOCK EXCHANGE RELEASE, 21 FEBRUARY 2023, 9:00 a.m.PONSSE’S FINANCIAL STATEMENTS FOR 1 JANUARY – 31 DECEMBER 2022October-December (continuing operations):– Net sales amounted to EUR 224.6 (173.2) million– Operating profit totalled EUR 11.7 (9.1) million, equalling 5.2 (5.3) per cent of net salesJanuary-December (continuing operations):– Net sales amounted to EUR 755.1 (608.3) million– Operating profit totalled EUR 46.6 (50.0) million, equalling 6.2 (8.2) per cent of net sales– Net result was EUR 34.2 (35.2) million– Earnings per share were EUR 1.22 (1.26)–

Fazer continues its systematic work to protect the Baltic Sea and renews its commitment with BSAG

Fazer works actively to reduce its environmental impact and has participated in protecting the Baltic Sea since 2013. Fazer makes now its third Baltic Sea commitment with the Baltic Sea Action Group (BSAG). Fazer is committed to developing its production, operating methods and product selection in ways that support the ecological balance of the Baltic Sea and other waterways. The aim of the protection work is that as few nutrients as possible end up in the water systems.Food production and consumption have a major impact on the environment, society and well-being. Fazer’s latest Baltic Sea

Devyser Diagnostics AB publishes Year-End Report for the period January to December 2022

“Further strong organic growth was reported for the year and quarter. Efforts to build an international marketing and sales organization are starting to pay off. I am confident that we will achieve our important financial target of generating an operating margin of more than 20% starting sometime in 2024/2026.” Fredrik Alpsten, CEO, Devyser Quarter October-December 2022 · Net sales amounted to SEK 34.2 million (24.5), corresponding to a 39.5% increase. Adjusted for exchange rate fluctuations, net sales increased by 29.8%. · Gross profit totaled SEK 27.2 million (18.5),

Webstep ASA: Key information relating to proposed cash dividend

Oslo, 21 February 2023: The board of directors of Webstep ASA has resolved to propose to the Annual General Meeting, to be held 4 May 2023, an ordinary dividend of NOK 1.70 per share for the fiscal year 2022.Dividend amount: NOK 1.70 per share Declared currency: NOK Last day including right: 4 May 2023 Ex-date: 5 May 2023 Record date: 8 May 2023 Payment date: On or about 16 May 2023 Date of approval:  4 May 2023

NRC Group ASA – Q4 2022 results

NRC Group today published its financial results for the fourth quarter of 2022. CEO Henning Olsen and CFO Ole Anton Gulsvik will present the results at 09:00 am (CET) at House of Oslo, Ruseløkkveien 34, Oslo. The presentation will also be webcast live on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20230221_2/ The presentation will be followed by a live Q&A-session. Investors, analysts and journalists are welcome to participate at House of Oslo or follow the presentation digitally, where questions can be submitted during the event. Below you will

Atlas Copco celebrates 150 years of innovations

Nacka, Sweden, February 21, 2023: Atlas Copco, founded in Stockholm in 1873, today celebrates its 150-year anniversary. During a century and a half, Atlas Copco has been driving development and delivering breakthrough innovations to customers in many different industries.“We are extremely proud of our past, and we continue to shape the future through our technologies and service solutions,” said Mats Rahmström, CEO and President of the Atlas Copco Group. “Much has changed since 1873 when we were a small local start-up. But I think our founders would recognize our innovative spirit, the

Webstep ASA: Fourth quarter and full year results 2022. Dividend proposal of NOK 1.70 per share

Oslo, 21 February 2023: Webstep ASA reports revenue of NOK 246.4 million ( NOK 218.8 million) and EBIT of NOK 11.8 million (NOK 18.4 million) for the fourth quarter. EBIT is impacted by one-off costs, and EBIT adjusted is NOK 17.2 million for the fourth quarter.One-off costs of NOK 5.4 million, are related to future overhead cost reduction and write-down of 2023 lease obligation.  For the full year, Webstep ASA reports revenue of NOK 888.4 million (NOK 775.0 million). EBIT for the year ended at NOK 54.6 million (NOK 65.9 million). EBIT adjusted is NOK 60.0 million for the full year. The

Operational EBIT of DKK 376 Million for the Fourth Quarter of 2022

(Figures in parenthesis refer to the same period last year unless otherwise specified) The Bakkafrost Group delivered a total operating EBIT of DKK 376 million (DKK 120 million) in Q4 2022 and made a profit of DKK -154 million (DKK -3 million). The combined FO farming and VAP segments made an operational EBIT of DKK 467 million (DKK 310 million). The FO farming segment made an operational EBIT of DKK 380 million (DKK 282 million). The SCT farming segment made an operational EBIT of DKK -149 million (DKK -214 million). The VAP segment made an operational EBIT of DKK 86 million (DKK 28

There are no items matching the current filter
There are no more items matching the current filter
Back to top